#United Imaging #South Africa #Cape Town #MRI Technology #uMR Jupiter

United Imaging's Groundbreaking MRI Advancements at ISMRM 2026

On May 20, 2026, in Cape Town, South Africa, United Imaging, a frontrunner in AI-powered medical imaging, unveiled its latest innovations at the International Society for Magnetic Resonance in Medicine (ISMRM) 2026. The company highlighted a robust portfolio of MRI technologies, demonstrating advancements in ultra-high field imaging, artificial intelligence, and enhanced research ecosystems.

uMR Jupiter: A Leap Beyond Conventional MRI

At the heart of the exhibition was the uMR Jupiter, a revolutionary whole-body 5T MRI system that sets new standards in ultra-high-field imaging. Unlike traditional MRI systems, which focus primarily on the brain and musculoskeletal joints, the uMR Jupiter expands its capabilities to the abdomen, heart, pelvis, and more. This system is designed to deliver unparalleled resolution and a superior signal-to-noise ratio compared to the standard 3T MRI systems, allowing radiologists to uncover details that were previously invisible.

Leveraging its high magnetic field strength, the uMR Jupiter specializes in multi-nuclear metabolic imaging. This includes the ability to use isotopes like deuterium and phosphorus for early detection of pathological changes—providing a significant advantage in disease management. This system's comprehensive whole-body coverage facilitates advanced metabolic imaging, crucial for understanding patient health.

uMR Ultra: Dynamic Imaging Redefined

In addition to the uMR Jupiter, United Imaging also introduced the uMR Ultra, an advanced 3T MRI system that captures and analyzes the body’s movements during scans. This capability marks a significant shift in MRI technology from static to dynamic imaging. The uMR Ultra incorporates remarkable features, such as a 100 mT/m gradient performance at 200 T/m/s and up to 192 independent receive channels, which are essential for overcoming the challenges of imaging motion.

To enhance this further, the uAIFI.LIVE platform offers a dynamic whole-body live imaging capability. Essentially, this transformation from static imaging to highly detailed motion visualization represents a paradigm shift in MRI capabilities, allowing for a more comprehensive examination of patients.

Pioneering Energy Efficiency with SiC Technology

Moreover, United Imaging presented the world’s first Silicon Carbide (SiC)-enhanced Gradient Power Amplifier (GPA), promising remarkable reductions in energy usage and carbon emissions. According to their study, this innovative technology can cut MRI energy consumption by over 57% while maintaining high image quality, making it essential for sustainable medical imaging practices.

The significant implications of these advancements were highlighted during the oral presentation of the study “Energy-saving Efficiency of a Novel Silicon Carbide MRI Gradient Power Amplifier” at the 2025 RSNA Annual Meeting, showcasing its clinical relevance and potential for leading the future of low-carbon MRI operations.

Supporting Research Ecosystems with ADEPT and AppCenter

Additionally, United Imaging is committed to supporting the scientific community through its ADEPT platform. This platform offers advanced hardware control and simplifies application development, playing a critical role in accelerating research in MRI technology. Paired with the AppCenter, which promotes application sharing and global collaboration among experts, these tools aim to enhance collective intelligence in MRI research.

In conclusion, United Imaging's presence at ISMRM 2026 not only showcased its innovations in MRI technology but also underscored its commitment to sustainable practices and supporting the research community. As the medical imaging sector continues to evolve, United Imaging stands out as a leader driving significant advancements to improve patient outcomes and expand the possibilities of MRI technology.

Note: The featured products are for research purposes only, pending regulatory clearance, and are not available for clinical use in the United States.